venBio Global Strategic Fund II L.P.
10% owner at Checkmate Pharmaceuticals, Inc.; 10% owner at AKRO
- Sold, on record
- $10.5M
- Dollars the filings state
- Form 4 sales
- 7
- Latest May 12, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Checkmate Pharmaceuticals, Inc.10% owner
- AKROAkero Therapeutics, Inc.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Checkmate Pharmaceuticals, Inc.437,604 shares
- AKRO211,467 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale AKROPlan not statedJan 7, 2020 2020
Sold 73,221 shares at $19.86 ($1.5M)
venBio Global Strategic Fund II L.P., 10% owner
Sold 1.9% of holdings ($77.6M position)3.8M shares leftFirst sale on recordFiling
- 2 Form 4 sale AKROPlan not statedJan 8, 2020 +1 day
Sold 15,677 shares at $19.86 ($311k)
venBio Global Strategic Fund II L.P., 10% owner
Sold 0.4% of holdings ($76.1M position)3.8M shares leftFiling
- 3 Form 4 sale AKROPlan not statedFeb 6, 2020 +29 days
Sold 6,102 shares at $27.03 ($165k)
venBio Global Strategic Fund II L.P., 10% owner
Sold 0.2% of holdings ($87.6M position)3.2M shares leftFiling
- 4 Form 4 sale AKROUnusualJul 6, 2020 +151 days
Sold 116,467 shares at $34.40 ($4M)
venBio Global Strategic Fund II L.P., 10% owner
Sold 3.7% of holdings ($108M position)3M shares left7.4x usual sizeFiling
- 5 Form 4 sale Checkmate Pharmaceuticals, Inc.Plan not statedApr 29, 2022 +662 days
Sold 190,026 shares at $10.38 ($2M)
venBio Global Strategic Fund II L.P., 10% owner
Sold 6.3% of holdings ($31.1M position)2.8M shares leftFirst sale on recordFiling
- 6 Form 4 sale Checkmate Pharmaceuticals, Inc.Plan not statedMay 9, 2022 +10 days
Sold 86,677 shares at $10.37 ($899k)
venBio Global Strategic Fund II L.P., 10% owner
Sold 3.4% of holdings ($26.3M position)2.4M shares leftFiling
- 7 Form 4 sale Checkmate Pharmaceuticals, Inc.Plan not statedMay 12, 2022 +3 days
Sold 160,901 shares at $10.39 ($1.7M)
venBio Global Strategic Fund II L.P., 10% owner
Sold 6.6% of holdings ($25.4M position)2.3M shares leftFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 12, 2022 | May 12, 2022 | Checkmate Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 160,901 | $1.7M | 6.6% | Plan not stated | SEC |
| May 9, 2022 | May 9, 2022 | Checkmate Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 86,677 | $899k | 3.4% | Plan not stated | SEC |
| Apr 29, 2022 | Apr 29, 2022 | Checkmate Pharmaceuticals, Inc. | 10% owner | Form 4 sale | 190,026 | $2M | 6.3% | Plan not stated | SEC |
| Jul 6, 2020 | Jul 6, 2020 | AKRO | 10% owner | Form 4 sale | 116,467 | $4M | 3.7% | Unusual | SEC |
| Feb 6, 2020 | Feb 10, 2020 | AKRO | 10% owner | Form 4 sale | 6,102 | $165k | 0.2% | Plan not stated | SEC |
| Jan 8, 2020 | Jan 10, 2020 | AKRO | 10% owner | Form 4 sale | 15,677 | $311k | 0.4% | Plan not stated | SEC |
| Jan 7, 2020 | Jan 8, 2020 | AKRO | 10% owner | Form 4 sale | 73,221 | $1.5M | 1.9% | Plan not stated | SEC |